The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Enoxaparin API Market Research Report 2024
Synopsis
Enoxaparin is made from heparin and is one type of the low molecular weight heparin (LMWH). It is used as an anticoagulant that prevents the formation of blood clots also known as ‘blood thinner’. It is used to treat various conditions including deep vein thrombosis (DVT), pulmonary embolism in the lungs, acute coronary syndrome and heart attack.
Global Enoxaparin API market is projected to reach US$ 1001.5 million in 2029, increasing from US$ 670 million in 2022, with the CAGR of 5.9% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Enoxaparin API market research.
Key manufacturers engaged in the Enoxaparin API industry include Pfizer Inc., Sanofi S.A., GlaxoSmithKline Plc, Bristol Myer Squibb Company, Bohehringer Ingelheim, Eisai Inc., Teva Pharmaceutical Industries Ltd., Abbot India Limited, Novartis AG and ChemWerth, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Enoxaparin API were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Enoxaparin API market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Enoxaparin API market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Pfizer Inc.
Sanofi S.A.
GlaxoSmithKline Plc
Bristol Myer Squibb Company
Bohehringer Ingelheim
Eisai Inc.
Teva Pharmaceutical Industries Ltd.
Abbot India Limited, Novartis AG
ChemWerth
Laboratorios Farmaceuticos ROVI SA
Gland Pharma Limited
Hanways Chempharma Co. Ltd
Changzhou Qianhong Biopharma
Shenzhen Hepalink Pharmaceutical Group
Segment by Type
Multi Vials
Pre-Filled Syringes
Others
Segment by Application
COVID-19
Pulmonary Embolism
Atrial Fibrillation
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
The Enoxaparin API report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Enoxaparin is made from heparin and is one type of the low molecular weight heparin (LMWH). It is used as an anticoagulant that prevents the formation of blood clots also known as ‘blood thinner’. It is used to treat various conditions including deep vein thrombosis (DVT), pulmonary embolism in the lungs, acute coronary syndrome and heart attack.
Global Enoxaparin API market is projected to reach US$ 1001.5 million in 2029, increasing from US$ 670 million in 2022, with the CAGR of 5.9% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Enoxaparin API market research.
Key manufacturers engaged in the Enoxaparin API industry include Pfizer Inc., Sanofi S.A., GlaxoSmithKline Plc, Bristol Myer Squibb Company, Bohehringer Ingelheim, Eisai Inc., Teva Pharmaceutical Industries Ltd., Abbot India Limited, Novartis AG and ChemWerth, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Enoxaparin API were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Enoxaparin API market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Enoxaparin API market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Pfizer Inc.
Sanofi S.A.
GlaxoSmithKline Plc
Bristol Myer Squibb Company
Bohehringer Ingelheim
Eisai Inc.
Teva Pharmaceutical Industries Ltd.
Abbot India Limited, Novartis AG
ChemWerth
Laboratorios Farmaceuticos ROVI SA
Gland Pharma Limited
Hanways Chempharma Co. Ltd
Changzhou Qianhong Biopharma
Shenzhen Hepalink Pharmaceutical Group
Segment by Type
Multi Vials
Pre-Filled Syringes
Others
Segment by Application
COVID-19
Pulmonary Embolism
Atrial Fibrillation
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
The Enoxaparin API report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 Enoxaparin API Market Overview
1.1 Product Overview and Scope of Enoxaparin API
1.2 Enoxaparin API Segment by Type
1.2.1 Global Enoxaparin API Market Value Comparison by Type (2023-2029)
1.2.2 Multi Vials
1.2.3 Pre-Filled Syringes
1.2.4 Others
1.3 Enoxaparin API Segment by Application
1.3.1 Global Enoxaparin API Market Value by Application: (2023-2029)
1.3.2 COVID-19
1.3.3 Pulmonary Embolism
1.3.4 Atrial Fibrillation
1.3.5 Others
1.4 Global Enoxaparin API Market Size Estimates and Forecasts
1.4.1 Global Enoxaparin API Revenue 2018-2029
1.4.2 Global Enoxaparin API Sales 2018-2029
1.4.3 Global Enoxaparin API Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Enoxaparin API Market Competition by Manufacturers
2.1 Global Enoxaparin API Sales Market Share by Manufacturers (2018-2023)
2.2 Global Enoxaparin API Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Enoxaparin API Average Price by Manufacturers (2018-2023)
2.4 Global Enoxaparin API Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Enoxaparin API, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Enoxaparin API, Product Type & Application
2.7 Enoxaparin API Market Competitive Situation and Trends
2.7.1 Enoxaparin API Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Enoxaparin API Players Market Share by Revenue
2.7.3 Global Enoxaparin API Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Enoxaparin API Retrospective Market Scenario by Region
3.1 Global Enoxaparin API Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Enoxaparin API Global Enoxaparin API Sales by Region: 2018-2029
3.2.1 Global Enoxaparin API Sales by Region: 2018-2023
3.2.2 Global Enoxaparin API Sales by Region: 2024-2029
3.3 Global Enoxaparin API Global Enoxaparin API Revenue by Region: 2018-2029
3.3.1 Global Enoxaparin API Revenue by Region: 2018-2023
3.3.2 Global Enoxaparin API Revenue by Region: 2024-2029
3.4 North America Enoxaparin API Market Facts & Figures by Country
3.4.1 North America Enoxaparin API Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Enoxaparin API Sales by Country (2018-2029)
3.4.3 North America Enoxaparin API Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Enoxaparin API Market Facts & Figures by Country
3.5.1 Europe Enoxaparin API Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Enoxaparin API Sales by Country (2018-2029)
3.5.3 Europe Enoxaparin API Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Enoxaparin API Market Facts & Figures by Country
3.6.1 Asia Pacific Enoxaparin API Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Enoxaparin API Sales by Country (2018-2029)
3.6.3 Asia Pacific Enoxaparin API Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Enoxaparin API Market Facts & Figures by Country
3.7.1 Latin America Enoxaparin API Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Enoxaparin API Sales by Country (2018-2029)
3.7.3 Latin America Enoxaparin API Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Enoxaparin API Market Facts & Figures by Country
3.8.1 Middle East and Africa Enoxaparin API Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Enoxaparin API Sales by Country (2018-2029)
3.8.3 Middle East and Africa Enoxaparin API Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Enoxaparin API Sales by Type (2018-2029)
4.1.1 Global Enoxaparin API Sales by Type (2018-2023)
4.1.2 Global Enoxaparin API Sales by Type (2024-2029)
4.1.3 Global Enoxaparin API Sales Market Share by Type (2018-2029)
4.2 Global Enoxaparin API Revenue by Type (2018-2029)
4.2.1 Global Enoxaparin API Revenue by Type (2018-2023)
4.2.2 Global Enoxaparin API Revenue by Type (2024-2029)
4.2.3 Global Enoxaparin API Revenue Market Share by Type (2018-2029)
4.3 Global Enoxaparin API Price by Type (2018-2029)
5 Segment by Application
5.1 Global Enoxaparin API Sales by Application (2018-2029)
5.1.1 Global Enoxaparin API Sales by Application (2018-2023)
5.1.2 Global Enoxaparin API Sales by Application (2024-2029)
5.1.3 Global Enoxaparin API Sales Market Share by Application (2018-2029)
5.2 Global Enoxaparin API Revenue by Application (2018-2029)
5.2.1 Global Enoxaparin API Revenue by Application (2018-2023)
5.2.2 Global Enoxaparin API Revenue by Application (2024-2029)
5.2.3 Global Enoxaparin API Revenue Market Share by Application (2018-2029)
5.3 Global Enoxaparin API Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Pfizer Inc.
6.1.1 Pfizer Inc. Corporation Information
6.1.2 Pfizer Inc. Description and Business Overview
6.1.3 Pfizer Inc. Enoxaparin API Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Pfizer Inc. Enoxaparin API Product Portfolio
6.1.5 Pfizer Inc. Recent Developments/Updates
6.2 Sanofi S.A.
6.2.1 Sanofi S.A. Corporation Information
6.2.2 Sanofi S.A. Description and Business Overview
6.2.3 Sanofi S.A. Enoxaparin API Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Sanofi S.A. Enoxaparin API Product Portfolio
6.2.5 Sanofi S.A. Recent Developments/Updates
6.3 GlaxoSmithKline Plc
6.3.1 GlaxoSmithKline Plc Corporation Information
6.3.2 GlaxoSmithKline Plc Description and Business Overview
6.3.3 GlaxoSmithKline Plc Enoxaparin API Sales, Revenue and Gross Margin (2018-2023)
6.3.4 GlaxoSmithKline Plc Enoxaparin API Product Portfolio
6.3.5 GlaxoSmithKline Plc Recent Developments/Updates
6.4 Bristol Myer Squibb Company
6.4.1 Bristol Myer Squibb Company Corporation Information
6.4.2 Bristol Myer Squibb Company Description and Business Overview
6.4.3 Bristol Myer Squibb Company Enoxaparin API Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Bristol Myer Squibb Company Enoxaparin API Product Portfolio
6.4.5 Bristol Myer Squibb Company Recent Developments/Updates
6.5 Bohehringer Ingelheim
6.5.1 Bohehringer Ingelheim Corporation Information
6.5.2 Bohehringer Ingelheim Description and Business Overview
6.5.3 Bohehringer Ingelheim Enoxaparin API Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Bohehringer Ingelheim Enoxaparin API Product Portfolio
6.5.5 Bohehringer Ingelheim Recent Developments/Updates
6.6 Eisai Inc.
6.6.1 Eisai Inc. Corporation Information
6.6.2 Eisai Inc. Description and Business Overview
6.6.3 Eisai Inc. Enoxaparin API Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Eisai Inc. Enoxaparin API Product Portfolio
6.6.5 Eisai Inc. Recent Developments/Updates
6.7 Teva Pharmaceutical Industries Ltd.
6.6.1 Teva Pharmaceutical Industries Ltd. Corporation Information
6.6.2 Teva Pharmaceutical Industries Ltd. Description and Business Overview
6.6.3 Teva Pharmaceutical Industries Ltd. Enoxaparin API Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Teva Pharmaceutical Industries Ltd. Enoxaparin API Product Portfolio
6.7.5 Teva Pharmaceutical Industries Ltd. Recent Developments/Updates
6.8 Abbot India Limited, Novartis AG
6.8.1 Abbot India Limited, Novartis AG Corporation Information
6.8.2 Abbot India Limited, Novartis AG Description and Business Overview
6.8.3 Abbot India Limited, Novartis AG Enoxaparin API Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Abbot India Limited, Novartis AG Enoxaparin API Product Portfolio
6.8.5 Abbot India Limited, Novartis AG Recent Developments/Updates
6.9 ChemWerth
6.9.1 ChemWerth Corporation Information
6.9.2 ChemWerth Description and Business Overview
6.9.3 ChemWerth Enoxaparin API Sales, Revenue and Gross Margin (2018-2023)
6.9.4 ChemWerth Enoxaparin API Product Portfolio
6.9.5 ChemWerth Recent Developments/Updates
6.10 Laboratorios Farmaceuticos ROVI SA
6.10.1 Laboratorios Farmaceuticos ROVI SA Corporation Information
6.10.2 Laboratorios Farmaceuticos ROVI SA Description and Business Overview
6.10.3 Laboratorios Farmaceuticos ROVI SA Enoxaparin API Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Laboratorios Farmaceuticos ROVI SA Enoxaparin API Product Portfolio
6.10.5 Laboratorios Farmaceuticos ROVI SA Recent Developments/Updates
6.11 Gland Pharma Limited
6.11.1 Gland Pharma Limited Corporation Information
6.11.2 Gland Pharma Limited Enoxaparin API Description and Business Overview
6.11.3 Gland Pharma Limited Enoxaparin API Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Gland Pharma Limited Enoxaparin API Product Portfolio
6.11.5 Gland Pharma Limited Recent Developments/Updates
6.12 Hanways Chempharma Co. Ltd
6.12.1 Hanways Chempharma Co. Ltd Corporation Information
6.12.2 Hanways Chempharma Co. Ltd Enoxaparin API Description and Business Overview
6.12.3 Hanways Chempharma Co. Ltd Enoxaparin API Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Hanways Chempharma Co. Ltd Enoxaparin API Product Portfolio
6.12.5 Hanways Chempharma Co. Ltd Recent Developments/Updates
6.13 Changzhou Qianhong Biopharma
6.13.1 Changzhou Qianhong Biopharma Corporation Information
6.13.2 Changzhou Qianhong Biopharma Enoxaparin API Description and Business Overview
6.13.3 Changzhou Qianhong Biopharma Enoxaparin API Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Changzhou Qianhong Biopharma Enoxaparin API Product Portfolio
6.13.5 Changzhou Qianhong Biopharma Recent Developments/Updates
6.14 Shenzhen Hepalink Pharmaceutical Group
6.14.1 Shenzhen Hepalink Pharmaceutical Group Corporation Information
6.14.2 Shenzhen Hepalink Pharmaceutical Group Enoxaparin API Description and Business Overview
6.14.3 Shenzhen Hepalink Pharmaceutical Group Enoxaparin API Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Shenzhen Hepalink Pharmaceutical Group Enoxaparin API Product Portfolio
6.14.5 Shenzhen Hepalink Pharmaceutical Group Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Enoxaparin API Industry Chain Analysis
7.2 Enoxaparin API Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Enoxaparin API Production Mode & Process
7.4 Enoxaparin API Sales and Marketing
7.4.1 Enoxaparin API Sales Channels
7.4.2 Enoxaparin API Distributors
7.5 Enoxaparin API Customers
8 Enoxaparin API Market Dynamics
8.1 Enoxaparin API Industry Trends
8.2 Enoxaparin API Market Drivers
8.3 Enoxaparin API Market Challenges
8.4 Enoxaparin API Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
